↓ Skip to main content

Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases

Overview of attention for article published in Radiation Oncology, July 2012
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases
Published in
Radiation Oncology, July 2012
DOI 10.1186/1748-717x-7-107
Pubmed ID
Authors

Jonathan E Leeman, David A Clump, Rodney E Wegner, Dwight E Heron, Steven A Burton, Arlan H Mintz

Abstract

Brainstem metastases represent an uncommon clinical presentation that is associated with a poor prognosis. Treatment options are limited given the unacceptable risks associated with surgical resection in this location. However, without local control, symptoms including progressive cranial nerve dysfunction are frequently observed. The objective of this study was to determine the outcomes associated with linear accelerator-based stereotactic radiotherapy or radiosurgery (SRT/SRS) of brainstem metastases.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 1%
Belgium 1 1%
Unknown 66 97%

Demographic breakdown

Readers by professional status Count As %
Other 14 21%
Student > Master 10 15%
Researcher 7 10%
Student > Ph. D. Student 6 9%
Student > Doctoral Student 5 7%
Other 15 22%
Unknown 11 16%
Readers by discipline Count As %
Medicine and Dentistry 39 57%
Physics and Astronomy 4 6%
Unspecified 2 3%
Nursing and Health Professions 2 3%
Neuroscience 2 3%
Other 3 4%
Unknown 16 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2012.
All research outputs
#20,182,546
of 22,696,971 outputs
Outputs from Radiation Oncology
#1,672
of 2,046 outputs
Outputs of similar age
#147,945
of 164,340 outputs
Outputs of similar age from Radiation Oncology
#35
of 35 outputs
Altmetric has tracked 22,696,971 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,046 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,340 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.